Extracorporeal Therapy and Therapeutic Drug Monitoring
NCT07287813 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 40
Last updated 2025-12-17
Summary
The aim of this study is to comparatively evaluate serum concentrations of continuously applied antibiotics in ICU patients, with and without ECMO/RRT support.
Conditions
- ICU Patients With ECMO And-or RRT and With Gram Negative Infections Susceptible to BL-BLIs
Sponsors & Collaborators
-
Fondazione IRCCS Policlinico San Matteo di Pavia
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-12-12
- Primary Completion
- 2027-01-31
- Completion
- 2027-01-31
Countries
- Italy
Study Locations
More Related Trials
-
Therapeutic Monitoring of Beta-lactams in Critically Ill Patients With Sepsis
NCT07270523 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
PK/PD Study of Anti-Infective Drugs in Critically Ill Patients Receiving Extracorporeal Membrane Oxygenation Treatment
NCT06319677 ·Status: NOT_YET_RECRUITING
-
Safety and Efficacy of Procalcitonin Guided Antibiotic Therapy in Adult Intensive Care Units (ICU's)
NCT01139489 ·Status: COMPLETED ·Phase: NA
-
The Distribution of Plasma Drug Concentrations of Beta-lactam Antibiotics in Intensive Care Unit Patients
NCT02446392 ·Status: COMPLETED
-
Early Use of Polymyxin B Hemoperfusion in Abdominal Sepsis
NCT00629382 ·Status: COMPLETED ·Phase: PHASE4
-
Multi-drug Resistant Gram-negative Bacteria and Veno-venous Extracorporeal Membrane Oxygenation (ECMO)
NCT06199141 ·Status: COMPLETED
-
Neurotoxicity Evaluation of Beta-lactams in Intensive Care Unit and Identification of the Risk Factors
NCT03628300 ·Status: COMPLETED
-
Pharmacokinetic Study of Antibiotics in Patients Assisted by Extracorporeal Membrane Oxygenation (PHARMECMO)
NCT03131063 ·Status: COMPLETED
-
Population Pharmacokinetics of Anti-infectives in Critically Ill Children
NCT02539407 ·Status: RECRUITING
-
An Observational Pharmacokinetic Sudy of Ceftolozane-Tazobactam in Intensive Care Unit in Patients With and Without CRRT
NCT02962934 ·Status: COMPLETED
-
The Effects of Polymyxin-B Protects on Sepsis Induced Kidney Dysfunction: a Randomized Clinical Trial
NCT00490477 ·Status: COMPLETED ·Phase: PHASE3
-
Beta-Lactam Antibiotics InitiaL ExpoSure OptimisEd in CriticallY Ill Patients with SEpsis
NCT06766461 ·Status: RECRUITING ·Phase: PHASE4
-
Procalcitonin Monitoring May Decrease Antibiotic Use in the Intensive Care Unit
NCT01085994 ·Status: UNKNOWN
-
PCT and Clinical Algorithm for Determination of Duration of Antibiotics
NCT01572831 ·Status: COMPLETED ·Phase: PHASE3
-
Observed Pharmacokinetic of Piperacillin/Tazobactam Compared to Amikacin in ICU
NCT03990467 ·Status: UNKNOWN ·Phase: NA
-
Piperacillin Pharmacokinetics in ICU Patients
NCT02478073 ·Status: UNKNOWN
-
Procalcitonin as a Tool to Shorten Antibiotic Therapy in the ICU
NCT01494675 ·Status: COMPLETED ·Phase: NA
-
Procalcitonin to Shorten Antibiotics Duration in ICU Patients
NCT01379547 ·Status: UNKNOWN ·Phase: PHASE3
-
Beta-lactam Intermittent Versus Continuous Infusion and Combination Antibiotic Therapy in Sepsis
NCT05681442 ·Status: RECRUITING ·Phase: PHASE4
-
Pharmacokinetic of Ceftriaxone in Septic ICU Patients
NCT00449800 ·Status: UNKNOWN ·Phase: PHASE4
-
Monitoring of Piperacillin-Tazobactam and Meropenem Plasmatic Levels in Critical Patients
NCT04257838 ·Status: UNKNOWN
-
Early Procalcitonin Kinetics During Empirical Antibiotic Therapy in Critically Ill Patients
NCT02294695 ·Status: COMPLETED
-
Citrate Versus Heparin Anticoagulation: Effect on Molecules Clearances
NCT01839578 ·Status: UNKNOWN ·Phase: NA
-
Duration of Antibiotic Therapy in Critically Ill Patients: C-reactive Protein-guided Therapy Versus Best Practice
NCT02987790 ·Status: COMPLETED ·Phase: NA
-
Procalcitonin Guided Versus Conventional Antibiotic Therapy in Patients With Sepsis in the ICU
NCT00987818 ·Status: WITHDRAWN ·Phase: NA